Patient empowerment for cancer patients through a novel ICT infrastructure.

Cancer Patient empowerment Personal health system Psychoemotional monitoring

Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
01 2020
Historique:
received: 09 11 2018
revised: 15 11 2019
accepted: 21 11 2019
pubmed: 10 12 2019
medline: 29 7 2021
entrez: 10 12 2019
Statut: ppublish

Résumé

As a result of recent advances in cancer research and "precision medicine" approaches, i.e. the idea of treating each patient with the right drug at the right time, more and more cancer patients are being cured, or might have to cope with a life with cancer. For many people, cancer survival today means living with a complex and chronic condition. Surviving and living with or beyond cancer requires the long-term management of the disease, leading to a significant need for active rehabilitation of the patients. In this paper, we present a novel methodology employed in the iManageCancer project for cancer patient empowerment in which personal health systems, serious games, psychoemotional monitoring and other novel decision-support tools are combined into an integrated patient empowerment platform. We present in detail the ICT infrastructure developed and our evaluation with the involvement of cancer patients on two sites, a large-scale pilot for adults and a small-scale test for children. The evaluation showed mixed evidences on the improvement of patient empowerment, while ability to cope with cancer, including improvement in mood and resilience to cancer, increased for the participants of the adults' pilot.

Identifiants

pubmed: 31816400
pii: S1532-0464(19)30261-8
doi: 10.1016/j.jbi.2019.103342
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103342

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Haridimos Kondylakis (H)

Computational BioMedicine Laboratory, FORTH-ICS, Heraklion, Greece. Electronic address: kondylak@ics.forth.gr.

Anca Bucur (A)

PHILIPS Research Europe, Eindhoven, The Netherlands.

Chiara Crico (C)

European Institute of Oncology, Milan, Italy.

Feng Dong (F)

Department of Computer Science and Technology, University of Bedfordshire, Luton, UK.

Norbert Graf (N)

Saarland University, Pediatric Oncology and Hematology, Homburg, Germany.

Stefan Hoffman (S)

Promotion Software GmbH, Berlin, Germany.

Lefteris Koumakis (L)

Computational BioMedicine Laboratory, FORTH-ICS, Heraklion, Greece.

Alice Manenti (A)

European Institute of Oncology, Milan, Italy.

Kostas Marias (K)

Computational BioMedicine Laboratory, FORTH-ICS, Heraklion, Greece.

Ketti Mazzocco (K)

European Institute of Oncology, Milan, Italy.

Gabriella Pravettoni (G)

European Institute of Oncology, Milan, Italy.

Chiara Renzi (C)

European Institute of Oncology, Milan, Italy.

Fatima Schera (F)

Fraunhofer Institute for Biomedical Engineering, Germany.

Stefano Triberti (S)

European Institute of Oncology, Milan, Italy.

Manolis Tsiknakis (M)

Computational BioMedicine Laboratory, FORTH-ICS, Heraklion, Greece.

Stephan Kiefer (S)

Fraunhofer Institute for Biomedical Engineering, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH